Top 100 1~2 Stewart Rahr Kinray 70 USA Top 100 1~2 Zeng Lingshan - 53, Top 100 1~2 Zhu & Bai Lihui Gloria Pharmaceuticals China 52 Top 100 1~2 Micheal Ypsomed 70 Switzerland Top 100 1~2 Bulent Eczacibasi Eczacibasi 67 Turkey Top 100 1~2 Eczacibasi Eczacibasi 62 Turkey Top 100 1~2 Wang Junmin Haisco Pharmaceutical 49 Top 100 1~2 GV Prasad Dr. Reddy's Lab 55 India Top 100 1~2 Lim Sung-Ki Hanmi Science 76 Korea Top 100 1~2 Che Fengsheng Sihuan 55 China Top 100 1~2 Xianfeng Xinfu Pharmaceutical 49 China Top 100 1~2 Dong Fan Jafron Biomedical 47 China 52, Top 100 1~2 Han Xu & Zhang Renhua Realcan Pharmaceutical China 51 Top 100 1~2 Li Zhengguo Youbo Pharmaceutical 57 China Top 100 1~2 Yang Wenlong & family Renhe 55 China Top 100 Zhang Simin & Wang 1~2 Neptunus 55, - China Jinsong Top 100 1~2 Zhu Wenchen Furen Medicine 51 China Francisco Deusmar de Top 100 1~2 Pague Menos 68 Brazil Queiros Top 100 1~2 Erwin Franz Mueller Mueller 84 Germany Top 100 1~2 K Satish Reddy Dr. Reddy's Lab 49 India Top 100 1~2 Rajeev Juneja Mankind Pharma 51 India Top 100 1~2 Ramesh Juneja Mankind Pharma 61 Top 100 1~2 Hirokazu Sugiara & family Sugi Holdings 66 Japan About Hurun Report Inc. Nobody Knows China’s Rich Better! Established as a research unit in 1999 by British accountant Rupert Hoogewerf, Hurun Report Inc. has grown into a leading research house, media and lifestyle investments business based in Shanghai, China, best-known for its rankings of the richest people in China, India and the rest of the world. Hurun Report Inc. has four divisions: Hurun Research Institute; Hurun Media; Hurun an active events division targeting entrepreneurs and high net worth Conferences and Training, individuals; and Hurun Lifestyle and Investments, with investments in education, interior design, horses, bespoke tailoring, media and retail.
Top 100 Stewart Rahr 1~2 Kinray 70 USA Top 100 Zeng Lingshan 1~2 - Top 100 Zhu & Bai Lihui 1~2 Gloria Pharmaceuticals 53, 52 China Top 100 Micheal 1~2 Ypsomed 70 Switzerland Top 100 Bulent Eczacibasi 1~2 Eczacibasi 67 Turkey Top 100 Eczacibasi 1~2 Eczacibasi 62 Turkey Top 100 Wang Junmin 1~2 Haisco Pharmaceutical 49 Top 100 GV Prasad 1~2 Dr. Reddy's Lab 55 India Top 100 Lim Sung-Ki 1~2 Hanmi Science 76 Korea Top 100 Che Fengsheng 1~2 Sihuan 55 China Top 100 Xianfeng 1~2 Xinfu Pharmaceutical 49 China Top 100 Dong Fan 1~2 Jafron Biomedical 47 China Top 100 Han Xu & Zhang Renhua 1~2 Realcan Pharmaceutical 52, 51 China Top 100 Li Zhengguo 1~2 Youbo Pharmaceutical 57 China Top 100 Yang Wenlong & family 1~2 Renhe 55 China Top 100 Zhang Simin & Wang Jinsong 1~2 Neptunus 55, - China Top 100 Zhu Wenchen 1~2 Furen Medicine 51 China Top 100 Francisco Deusmar de Queiros 1~2 Pague Menos 68 Brazil Top 100 Erwin Franz Mueller 1~2 Mueller 84 Germany Top 100 K Satish Reddy 1~2 Dr. Reddy's Lab 49 India Top 100 Rajeev Juneja 1~2 Mankind Pharma 51 India Top 100 Ramesh Juneja 1~2 Mankind Pharma 61 Top 100 Hirokazu Sugiara & family 1~2 Sugi Holdings 66 Japan About Hurun Report Inc. Nobody Knows China’s Rich Better! Established as a research unit in 1999 by British accountant Rupert Hoogewerf, Hurun Report Inc. has grown into a leading research house, media and lifestyle investments business based in Shanghai, China, best-known for its rankings of the richest people in China, India and the rest of the world. Hurun Report Inc. has four divisions: Hurun Research Institute; Hurun Media; Hurun Conferences and Training, an active events division targeting entrepreneurs and high net worth individuals; and Hurun Lifestyle and Investments, with investments in education, interior design, horses, bespoke tailoring, media and retail.
201709121418383669063.docx